Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
IASLC Journals Share Exciting Milestones on Metrics Journeys
lungcanc
Global Warming, COVID-19, and Lung Cancer: Why Lung Cancer Doctors Should...
lungcanc
Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication
lungcanc
Tobacco Use Assessment and Cessation Support: More Important Now Than Ever
lungcanc
The Chen-Huang Center for EGFR-Mutant Lung Cancers Represents a ‘Concentrated and...
lungcanc
Bringing Telehealth to the Front Lines of Lung Cancer Care in...
lungcanc
Conducting a Lung Multidisciplinary Tumor Board at the National University Cancer...
lungcanc
Patient Perspectives on Telehealth During COVID-19: Balancing Fear, Self-Advocacy
lungcanc
Building and Maintaining a Patient–Physician Relationship in the COVID-19 Era
lungcanc
A Roadmap to Improving Lung Cancer Care in the Middle East...
lungcanc
1
2
3
...
53
Page 2 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
